Skip to main content
Numinus Wellness and the Multidisciplinary Association for Psychedelic Studies Public Benefit Corp. (MAPS PBC), a MAPS subsidiary, have announced they are seeking approval for the use of MDMA-assisted psychotherapy for post-traumatic stress disorder through a compassionate access trial in Canada.
Field Trip Health, a Toronto-based psychedelic therapy and drug development firm, announced a partnership with Whoop, a membership-based health services company, to measure the effects of Field Trip’s psychedelic therapies.
Numinus Wellness, a mental health and wellness company based in Vancouver, British Columbia, announced plans to conduct a compassionate access clinical trial for psilocybin-assisted psychotherapy for the treatment of substance use disorders.
Doses of psilocybin, provided in combination with supporting psychotherapy, was found to produce significant reductions in symptoms of major depression in a study conducted by researchers at Johns Hopkins University.
The Oregon Health Authority will have two years to establish a state Psilocybin Services Program, which will license facilities to produce, administer and sell psilocybin products, while Washington, D.C. has decriminalized non-commercial cultivation, distribution, possession and use of a range of psychedelic plants and fungi.
Back to Top